JSI
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- Undisclosed
Investors
- 9
About JSI
Established in 2010 and based in Shanghai, China, JSI operates as a pharmaceutical R&D service provider that focuses on new small molecule anti-cancer drugs. Mr. Jintao Zhang once served as CEO and co-founder of Shanghai Medicilon Inc. The company provides new small molecule anti-cancer drugs. The business of the company includes drug molecular design, drug synthesis and evaluation of biological activity in vitro and in vivo. The product of the company includes VIC-1911, JSI-1187 and E6201. The company will increase investment in researching and developing core product.
Who invested in JSI
9 investors across 3 rounds
See all investors in JSI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about JSI
Who invested in JSI?
JSI has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has JSI raised?
JSI has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did JSI last raise money?
JSI's most recent round on record is a Series B, in Nov 2021.
What does JSI do?
Established in 2010 and based in Shanghai, China, JSI operates as a pharmaceutical R&D service provider that focuses on new small molecule anti-cancer drugs.
Where is JSI headquartered?
JSI is headquartered in Shanghai, China.
Which VCs invest in companies like JSI?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at JSI's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like JSI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.